Discover how Sharon and Orlaith are transforming access to cancer treatment
- We’re proud to announce that Shorla Oncology co-founders Sharon Cunningham (CEO) and Orlaith Ryan (CTO) have been named finalists in the EY Entrepreneur of the Year™ 2025 Ireland program. Celebrated for their leadership in specialty oncology, Sharon and Orlaith are driving meaningful change in cancer care by developing FDA-approved treatments that address critical gaps and unmet needs in oncology.
